NASDAQ: NRC - National Research Corporation

Altı ay boyunca karlılık: -33.17%
Temettü getirisi: +2.06%
Sektör: Healthcare

Promosyon programı National Research Corporation


Şirket hakkında National Research Corporation

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

daha fazla ayrıntı
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

IPO date 1997-10-10
ISIN US6373722023
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.72
Дивиденд ао 0.48
Сайт https://www.nrchealth.com
Цена ао 14.59
Günlük fiyat değişimi: +1.64% (14.59)
Haftalık fiyat değişimi: -1.85% (15.11)
Aylık fiyat değişimi: -14.03% (17.25)
3 ayda fiyat değişimi: -16.64% (17.79)
Altı ayda fiyat değişimi: -33.17% (22.19)
Yıllık fiyat değişimi: -62.38% (39.42)
3 yılda fiyat değişimi: -60.76% (37.79)
5 yılda fiyat değişimi: -78.48% (68.92)
Yılbaşından bu yana fiyat değişimi: -13.68% (17.18)

Hafife alma

İsim Anlam Seviye
P/S 6.63 1
P/BV 20.11 1
P/E 31.79 5
EV/EBITDA 22.12 5
Toplam: 4.13

Yeterlik

İsim Anlam Seviye
ROA, % 25.3 8
ROE, % 63.26 10
Toplam: 7.33

Temettüler

İsim Anlam Seviye
Div yield, % 2.06 5.15
DSI 0.8571 8.57
Toplam: 5.63

Görev

İsim Anlam Seviye
Debt/EBITDA 0.8109 9
Toplam: 8.4

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 16.08 3
karlılık Ebitda, % -4.4 0
karlılık EPS, % -0.3763 0
Toplam: 0.6

ETFPaylaşmak, %Yıllık karlılık, %Temettüler, %
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.06502 18.2 1.66828
iShares Russell 2000 Growth ETF 0.02498 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.01365 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.01365 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.00669 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00669 391.25 1.60498
iShares Russell 3000 ETF 0.00055 24.83 1.43482
SPDR Portfolio Europe ETF 0.00011 8.94 3.66537
Dimensional International Core Equity 2 ETF 0.00006 6.52 3.69996
0.01126.61.75



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Michael D. Hays Founder, CEO, President & Director 131.11k 1955 (70 yıllar)
Ms. Helen L. Hrdy Chief Customer Officer 291.51k 1965 (60 yıllar)
Mr. Jon Boumstein Chief Delivery Officer N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A 1973 (52 yıl)
Mr. Andy Monnich Chief Corporate Development Officer N/A 1976 (49 yıllar)
Mr. Jason Hahn Chief Revenue Officer N/A 1972 (53 yıl)
Ms. Linda Stacy Secretary N/A
Ms. Vinitha Ramnathan Chief Product Officer

Adres: United States, Lincoln. NE, 1245 Q Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.nrchealth.com